Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tacrolimus versus cyclosporine eye drops in children with severe active vernal keratoconjunctivitis
2008-001502-17Phase 3Active
- Sponsor
- Meyer Children's Hospital IRCCS
- Start
- Mar 2008
- Modality
- RNA-Targeting Small Molecules → Nucleic Acid-Directed Small Molecules → Small Molecules, Small Molecules, Peptides
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of tacrolimus and cyclosporine in Vernal Keratoconjunctivitis (VKC) (2 arms), sponsored by Meyer Children's Hospital IRCCS. Primary endpoints: Efficacy endpoint and Safety endpoint. Started Mar 2008; status: active.
02
Drugs
tacrolimuscyclosporine
03
Conditions
Vernal Keratoconjunctivitis (VKC)
Beyond the preview
Go deeper on 2008-001502-17.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-001502-17.